Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, V. P.
Right arrow Articles by Hayes, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, V. P.
Right arrow Articles by Hayes, J. D.
[Cancer Research 60, 957-969, February 15, 2000]
© 2000 American Association for Cancer Research


Epidemiology and Prevention

Chemoprevention of Aflatoxin B1 Hepatocarcinogenesis by Coumarin, a Natural Benzopyrone That Is a Potent Inducer of Aflatoxin B1-Aldehyde Reductase, the Glutathione S-Transferase A5 and P1 Subunits, and NAD(P)H:Quinone Oxidoreductase in Rat Liver1

Vincent P. Kelly2, Elizabeth M. Ellis2,3, Margaret M. Manson, Simon A. Chanas, Graeme J. Moffat, Ronald McLeod, David J. Judah, Gordon E. Neal and John D. Hayes4

Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland [V. P. K., E. M. E., S. A. C., R. M., J. D. H.]; Medical Research Council Toxicology Unit, Hodgkin Building, University of Leicester, Leicester LE1 9HN, England [M M. M., D. J. J., G. E. N.]; Zeneca Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, England [G. J. M.], United Kingdom

Structurally diverse compounds can confer resistance to aflatoxin B1 (AFB1) hepatocarcinogenesis in the rat. Treatment with either phytochemicals [benzyl isothiocyanate, coumarin (CMRN), or indole-3-carbinol] or synthetic antioxidants and other drugs (butylated hydroxyanisole, diethyl maleate, ethoxyquin, ß-naphthoflavone, oltipraz, phenobarbital, or trans-stilbene oxide) has been found to increase hepatic aldo-keto reductase activity toward AFB1-dialdehyde and glutathione S-transferase (GST) activity toward AFB1-8,9-epoxide in both male and female rats. Under the conditions used, the natural benzopyrone CMRN was a major inducer of the AFB1 aldehyde reductase (AFAR) and the aflatoxin-conjugating class-{alpha} GST A5 subunit in rat liver, causing elevations of between 25- and 35-fold in hepatic levels of these proteins. Induction was not limited to AFAR and GSTA5: treatment with CMRN caused similar increases in the amount of the class-{pi} GST P1 subunit and NAD(P)H:quinone oxidoreductase in rat liver. Immunohistochemistry demonstrated that the overexpression of AFAR, GSTA5, GSTP1, and NAD(P)H:quinone oxidoreductase affected by CMRN is restricted to the centrilobular (periacinar) zone of the lobule, sometimes extending almost as far as the portal tract. This pattern of induction was also observed with ethoxyquin, oltipraz, and trans-stilbene oxide. By contrast, induction of these proteins by ß-naphthoflavone and diethyl maleate was predominantly periportal. Northern blotting showed that induction of these phase II drug-metabolizing enzymes by CMRN was accompanied by similar increases in the levels of their mRNAs. To assess the biological significance of enzyme induction by dietary CMRN, two intervention studies were performed in which the ability of the benzopyrone to inhibit either AFB1-initiated preneoplastic nodules (at 13 weeks) or AFB1-initiated liver tumors (at 50 weeks) was investigated. Animals pretreated with CMRN for 2 weeks prior to administration of AFB1, and with continued treatment during exposure to the carcinogen for a further 11 weeks, were protected completely from development of hepatic preneoplastic lesions by 13 weeks. In the longer-term dietary intervention, treatment with CMRN before and during exposure to AFB1 for a total of 24 weeks was found to significantly inhibit the number and size of tumors that subsequently developed by 50 weeks. These data suggest that consumption of a CMRN-containing diet provides substantial protection against the initiation of AFB1 hepatocarcinogenesis in the rat.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
X. J. Wang, J. D. Hayes, C. J. Henderson, and C. R. Wolf
Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
PNAS, December 4, 2007; 104(49): 19589 - 19594.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. D. Seidel, S.-C. Hung, H Lynn Kan, and B Bhaskar Gollapudi
Background Gene Expression in Rat Kidney: Influence of Strain, Gender, and Diet
Toxicol. Sci., November 1, 2006; 94(1): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Prince, C. T. Campbell, T. A. Robertson, A. J. Wells, and H. E. Kleiner
Naturally occurring coumarins inhibit 7,12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland
Carcinogenesis, June 1, 2006; 27(6): 1204 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Y. Shih, P. Li, and T. H. Murphy
A Small-Molecule-Inducible Nrf2-Mediated Antioxidant Response Provides Effective Prophylaxis against Cerebral Ischemia In Vivo
J. Neurosci., November 2, 2005; 25(44): 10321 - 10335.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Y. Shih, S. Imbeault, V. Barakauskas, H. Erb, L. Jiang, P. Li, and T. H. Murphy
Induction of the Nrf2-driven Antioxidant Response Confers Neuroprotection during Mitochondrial Stress in Vivo
J. Biol. Chem., June 17, 2005; 280(24): 22925 - 22936.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. K. McWalter, L. G. Higgins, L. I. McLellan, C. J. Henderson, L. Song, P. J. Thornalley, K. Itoh, M. Yamamoto, and J. D. Hayes
Transcription Factor Nrf2 Is Essential for Induction of NAD(P)H:Quinone Oxidoreductase 1, Glutathione S-Transferases, and Glutamate Cysteine Ligase by Broccoli Seeds and Isothiocyanates
J. Nutr., December 1, 2004; 134(12): 3499S - 3506S.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Ellinger-Ziegelbauer, B. Stuart, B. Wahle, W. Bomann, and H.-J. Ahr
Characteristic Expression Profiles Induced by Genotoxic Carcinogens in Rat Liver
Toxicol. Sci., January 1, 2004; 77(1): 19 - 34.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. R. Jowsey, Q. Jiang, K. Itoh, M. Yamamoto, and J. D. Hayes
Expression of the Aflatoxin B1-8,9-Epoxide-Metabolizing Murine Glutathione S-Transferase A3 Subunit Is Regulated by the Nrf2 Transcription Factor through an Antioxidant Response Element
Mol. Pharmacol., November 1, 2003; 64(5): 1018 - 1028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. McMahon, K. Itoh, M. Yamamoto, and J. D. Hayes
Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression
J. Biol. Chem., June 6, 2003; 278(24): 21592 - 21600.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. M. Ellis, C. M. Slattery, and J. D. Hayes
Characterization of the rat aflatoxin B1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter
Carcinogenesis, April 1, 2003; 24(4): 727 - 737.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. E. Kleiner, S. V. Vulimiri, M. F. Starost, M. J. Reed, and J. DiGiovanni
Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice
Carcinogenesis, October 1, 2002; 23(10): 1667 - 1675.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Guyonnet, C. Belloir, M. Suschetet, M.-H. Siess, and A.-M. Le Bon
Mechanisms of protection against aflatoxin B1 genotoxicity in rats treated by organosulfur compounds from garlic
Carcinogenesis, August 1, 2002; 23(8): 1335 - 1341.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-A. Sun, L.-Y. Wang, C.-J. Chen, S.-N. Lu, S.-L. You, L.-W. Wang, Q. Wang, D.-M. Wu, and R. M. Santella
Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan
Carcinogenesis, August 1, 2001; 22(8): 1289 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bonnesen, I. M. Eggleston, and J. D. Hayes
Dietary Indoles and Isothiocyanates That Are Generated from Cruciferous Vegetables Can Both Stimulate Apoptosis and Confer Protection against DNA Damage in Human Colon Cell Lines
Cancer Res., August 1, 2001; 61(16): 6120 - 6130.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. McMahon, K. Itoh, M. Yamamoto, S. A. Chanas, C. J. Henderson, L. I. McLellan, C. R. Wolf, C. Cavin, and J. D. Hayes
The Cap 'n' Collar Basic Leucine Zipper Transcription Factor Nrf2 (NF-E2 p45-related Factor 2) Controls Both Constitutive and Inducible Expression of Intestinal Detoxification and Glutathione Biosynthetic Enzymes
Cancer Res., April 1, 2001; 61(8): 3299 - 3307.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. T. Dinkova-Kostova, M. A. Massiah, R. E. Bozak, R. J. Hicks, and P. Talalay
From the Cover: Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups
PNAS, March 13, 2001; 98(6): 3404 - 3409.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. E. Kleiner, S. V. Vulimiri, L. Miller, W. H. Johnson Jr, C. P. Whitman, and J. DiGiovanni
Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice
Carcinogenesis, January 1, 2001; 22(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.G. Shepherd, M. M. Manson, H. W.L. Ball, and L. I. McLellan
Regulation of rat glutamate-cysteine ligase ({gamma}-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B1-induced preneoplasia
Carcinogenesis, October 1, 2000; 21(10): 1827 - 1834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.